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Abstract
Objective: The incidence of bronchiectasis has declined markedly in developed countries. However, a reasonable number of patients still
need surgery, despite aggressive physiotherapy and antibiotic therapy. We have reviewed our patients to clarify the bene®ts from surgery and
to analyse the complications. Material and methods: Between 1988 and 1999, we have operated on 119 patients with bronchiectasis, 71
female and 48 male, with a mean age of 42.2 years (range 11±77 years). Surgery was indicated because of unsuccessful medical therapy in 66
patients (55%), 31 (26%) had haemoptysis, 11 (9.2%) had lung abscess, 10 (8.4%) had lung masses, and three (2.5%) had pneumothorax. The
most common manifestations were cough with sputum in 90 patients (76%), haemoptysis in 45 (38%) and recurrent infections in 57 (48%).
The mean duration of the symptoms was 4 years (range 1±40 years). The lower lobes were diseased in 61 patients and bilateral disease was
found in ten. The mean number of involved pulmonary segments was ®ve (range 1±15). A lobectomy was performed in 75 patients (62%), a
segmentectomy in 12 (10%), a pneumonectomy in nine (7.4%) and a bilobectomy in four (3.3%). Complete resection of the disease was
achieved in 108 cases (91%). Results: There was no operative mortality and perioperative morbidity occurred in 15 patients (15%), including
temporary broncho-pleural ®stulae in 7 (5.8%), and post-operative haemorrhage and atrial arrhythmias in four (3.3%) each. After a mean
follow-up was 4.5 years, 73 patients (68%) of this group were asymptomatic, and 31 (29%) had meaningful clinical improvement, while only
four (3.7%) maintained or worsened prior symptoms. The best clinical improvement occurred in patients with complete resection of the
disease (P  0:008). There were no differences in the respiratory function, comparing pre- and post-operative data, with a 2-year of
minimum interval. The VC was 91 and 89% and the FEV1 was 83% and 81% of expected, respectively before and after surgery,
(P NS). Conclusion: Surgery of pulmonary bronchiectasis has few complications and markedly improves symptoms in the great majority
of patients, especially when complete resection of the disease is achieved. Pulmonary resection of bronchiectasis does not alter respiratory
function. q 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Bronchiectasis are anomalous and irreversible dilatations
of the bronchi, caused by destruction of the elastic and
muscular layers of the bronchial wall, most frequently by
recurrent infection. Gradually, the pus-®lled bronchial sacs
make gas exchange impossible, resulting in an infected,
non-functioning lung segment.
Laennec made the ®rst description of this entity in 1819
[1]. In the pre-antibiotic era, it occurred frequently and was
incapacitating in most of cases and mortal in some. With
improvement of health care, the generalised use of antibio-
tics and of vaccines, and the control of tuberculosis, the
incidence and severity were markedly reduced. Although
bronchiectasis still constitute an important problem in the
poorer regions of the world, the prevalence in developed
countries is now estimated at less than 0.6/1000 persons [2].
Physiotherapy, with postural drainage, and antibiotic
therapy are now widely used in the management of bronch-
iectasis but, despite improvements, medical management of
bronchiectasis still led to mortality rates of 19±31% [3]. By
contrast, the mortality rate of surgical treatment has been
reported to be of 2±8%. Resection of the involved lung
segments in patients with unilateral disease remains the
only potential possibility of cure. Brunn and Nissen [4], in
1929, were the pioneers of the surgical treatment of bronch-
iectasis and, Jackson and Huber [5], in 1943, described the
basic principles of the surgical technique still in use today.
In order to evaluate the role of the surgical treatment of
bronchiectasis in our own conditions, we reviewed our
recent experience with 119 patients operated on from
1988 and analysed the indications and the long-term results.
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2. Material and methods
2.1. Patients
Between January 1988 and 1999, 1194 patients, with a
mean age of 49.6 years, were admitted for diagnosis and
treatment of bronchiectasis. Of these, 119 underwent
pulmonary resection. We analysed their in-hospital records
retrospectively. The mean age of the patients was 42.2 years
(range 11±77 years) and there were 71 females (60%). All
patients had chronic symptoms for a mean time of 4 years
(range 1±40 years), including productive cough in 76%,
recurrent infections in 48%; haemoptysis in 38% and severe
pneumonias in 15%. All patients had prior medical therapy
for a mean 30 months (range 2 months±30 years).
Thirty-®ve (29.5%) patients had a history of pulmonary
disease, including pulmonary tuberculosis in 21, asthma in
11 and silicosis in two. Several associated pathological enti-
ties contributed to the development of bronchiectasis (Table
1). In our country, there is still a high incidence of pulmon-
ary tuberculosis; hence a signi®cant number of our patients
(21; 18%) had a history of tuberculosis.
The initial, presumptive diagnosis was based on the clin-
ical manifestations. All patients were studied with a PA and
lateral X-ray of the thorax and all but 12 had a computed
tomography (CT) scan. Fiberoptic bronchoscopy was
performed in 78 patients (65.5%) and a bronchography in
48 (40%). One hundred and one patients (91.0%) had
respiratory function tests, the majority (66%) showing
normal ventilatory patterns. The remainder showed a
mixed or obstructive ventilatory pattern.
The disease was bilateral (evidence of involvement of
both lungs on either chest-X ray or CT scan, or by contrast
bronchography) in 10 patients (9%) and unilateral in 109
(92%), of the right chest in 63 (57%) and of the left in 46
(43%) (Table 2). It predominated in the basal segments
(67% of the patients) and was localised to the middle lobe
only in 34 (28%). The lingula was involved in seven patients
and two or more lobes were diseased in 25 patients. There
were a mean of ®ve segments affected (range 1±15
segments).
Frequent exacerbations of the disease, interfering with
normal professional or social life, or the need of hospitalisa-
tion were considered as failure of medical treatment and led
to surgery in 66 patients (55%). We do not usually follow
medically-treated patients, and the decision to present the
patient for surgery was made by the respective physicians,
but the ®nal decision was reached together at the weekly
medico-surgical meeting.
Other indications for surgery, usually urgent or emergent,
were persistent or severe hemoptysis in 31 (26%), lung
abscess in 11 (9%), lung mass in 10 (8%) and secondary
pneumothorax in three (3%). Haemoptysis (14; 67%)
constituted the most frequent indication for surgery in
patients with a history of pulmonary tuberculosis.
2.2. Operative technique
Before surgery, the respiratory condition of the patients
was optimised by respiratory-oriented physiotherapy, by
therapeutic bronchoscopy and by a two-week course of anti-
biotic therapy, speci®c to the result of the bronchial aspirate.
Most frequently, there was a mixed bacterial ¯ora, typical of
the oropharynx, the most frequent being the Hemophylus
in¯uenzae and the Streptococcus pneumoniae, followed by
Staphylococcus aureus, gram-negative bacilli and Pseudo-
monas aeruginosa. Patients with the diagnosis of tubercu-
losis were subjected to speci®c treatment in accordance with
the of®cial protocols. There were no cases of multiresistant
mycobacteria.
During anaesthesia, an epidural catheter was placed (L4±
L5) for regional analgesia with morphine, which was
continued for the ®rst two or three post-operative days.
Tracheal intubation with a double-lumen tube to avoid
contralateral spillage of pus and secretions was carried
out. Currently, toilet-bronchoscopy is performed routinely
preoperatively, after intubation. With the patient positioned
on a lateral decubitus, a posterolateral thoracotomy was
performed through the ®fth intercostal space.
A right thoracotomy was done in 74 patients and a left
thoracotomy in 47. Surgical resection aimed at minimising
the number of resected segments, without compromising the
objective of elimination of the disease. The surgical proce-
dures performed were pneumonectomy in nine patients
(8%), bilobectomy in four (3%), lobectomy in 75 (62%),
lobectomy plus segmentectomy in 17 (14%) and segmen-
tectomy or wedge resection in 16 (13%). Pulmonary resec-
tion was considered complete if the patient was believed to
be free of bronchiectasis after thoracotomy, and was
achieved in 108 patients (91%). In the remaining 11
patients, in whom other pathology was present, resection
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Table 1
Predisposing factors for bronchiectasis in 119 patients
Chronic respiratory infection 35 (30%)
Pulmonary tuberculosis 21 (18%)
Severe pneumonia 17 (14%)
Pulmonary sequestration 3
Immunode®ciency (IgG,IgA) 4
a-1 antitrypsin de®ciency 3
Congenital cystic adenomatoid malformation 2
Primary ciliary dyskinesia 1
Table 2
Localisation of the disease
Right lung (73) Left lung (56)
Upper lobe 10 8
Middle lobe/lingula 34 10
Inferior lobe 17 16
Multilobar 9 16
Basal segments 35 44
Total 105 (53%) 94 (47%)
was considered palliative. Eight of these patients had bilat-
eral bronchiectasis and three had tuberculosis. In addition,
three patients had a-1 antitrypsin de®ciency, two had
chronic bronchitis and one had primary ciliary dyskinesia.
A pneumonectomy was required in ®ve (24%) of the
patients with a history of tuberculosis and a lobectomy in
12 (57%). Only two of the ten patients who had bilateral
disease were operated on both lungs. In these cases the
clinically or radiologically worst side is operated on ®rst.
To minimize the risk of ®stulae, the bronchial stump was
routinely covered by a ¯ap of mediastinal pleura and/or
tissue. All the lung specimens resected had pathologic
con®rmation of bronchiectasis (Fig. 1).
Respiratory physiotherapy was re-initiated in the ®rst
post-operative day, and continued throughout hospital
admission and for at least one month after discharge. In
the absence of drainage or air leakage, the drains were
removed on the second or third post-operative day. Virtually
all patients had speci®c or large-spectrum intravenous anti-
biotic therapy for 5 days. Although there were no cases of
active infection, patients with a history of pulmonary tuber-
culosis were subjected to a minimum of three months of
prophylactic speci®c antibiotics.
2.3. De®nitions and statistical analysis
Statistical signi®cance of non-continuous data was deter-
mined using the x2 test or Fisher's exact test. Functional
results were compared pre and post-operatively for each
follow-up patient, and statistical analysis was carried out
by the paired t-test and/or Wilcoxon's rank test. A P-
value greater than 0.05 was considered non-signi®cant.
3. Results
There was no hospital mortality. Morbidity was observed
in 15 patients (15%), including post-operative haemorrhage
requiring re-exploration in four patients (3%) and persistent
air leakage in seven (6%). Six of the latter were successfully
treated by tetracycline-pleurodesis, around the 7th post-
operative day, and one required surgical reintervention for
closure of the ®stula. Four patients (3%) had severe supra-
ventricular arrhythmias, all controlled pharmacologically.
The length of hospital admission was 6±20 days (mean
8.5 days). The follow-up was complete for 108 patients
(91%), 97 of whom had complete resection (90.7%) and
11 of whom had incomplete resection (100%), with a
mean time of 4.5 years (range 1±10 years). The patients
were subjected to direct clinical evaluation. Seventy-three
(67.6%) were asymptomatic and 31 (29%) were improved
with regard to pre-operative symptoms. Only four patients
(4%) had shown no improvement (Table 3). The best clin-
ical improvement of this group was observed in patients
with complete resection of the disease (96 of 97 patients
followed; 99%), where only one patient was not improved.
By contrast, only one of 11 patients who had incomplete
resection was asymptomatic and three (27%) had shown no
improvement at all (P  0:008).
The results of the functional respiratory evaluation of the
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Fig. 1. All the lung specimens resected had pathologic con®rmation of bronchiectasis.
follow-up group, with a minimum interval of two years, are
shown in Table 4. There were no signi®cant differences
between pre- and post-operative data and the majority of
patients had normal or near normal ventilatory function.
4. Discussion
In this study, we observed that the basal segments of the
lower lobes were the most frequently affected (56%), espe-
cially the postero-basal segments. We would have expected
it more frequently on the left side, because of a greater
dif®culty in drainage of the left main bronchus (due to its
smaller diameter and greater angulation), and to its special
relationship with the left pulmonary artery [7,8]. However,
unlike other studies [6], we had more patients with right
lung involvement. Nonetheless, 57% of the basal segments
affected were of the left lung and the greater involvement of
the right lung in our series resulted from a frequent involve-
ment of the middle lobe. This is usually the result of regio-
nal lymphoid reaction to in¯ammatory and infectious
processes, which cause lymph node enlargement, with
extrinsic compression of the narrow intermediate bronchus,
impairing drainage (middle lobe syndrome).
The presumptive diagnosis of bronchiectasis is still
prompted by the clinical ®ndings. Although the chest X-
ray is a poorly sensitive diagnostic instrument, being normal
in more than 20% of the limited forms, we have utilised it
routinely as a screening tool. Indirect signs of bronchiectasis
are circular and tubular shadows, loss of volume, compen-
satory hyperin¯ation, signs of pulmonary artery hyper-
tension and parenchymal destructuration pattern (honey-
combing) [9]. Classically bronchography was routinely
used for con®rmation of the diagnosis and for de®nition
of the extension of the disease, but the unusual proportions
of bronchography and CT scans used in our series re¯ects
the transitory period covered. The use of bronchography has
been steadily decreasing (it was used in 40% of our patients,
mostly in the beginning of the series) and has been progres-
sively replaced by computed tomography (CT) scans (used
in 82%). Although bronchography achieves excellent topo-
graphical diagnosis of segment by segment from the surgi-
cal point of view, high-resolution CT scans, especially, have
a high sensitivity and speci®city and are easier to perform
[10,11]. CT scans are also more appropriate for use in
patients with severely affected pulmonary function, bronch-
ospasm and acute infection.
Fiberoptic bronchoscopy was performed in 78 of our
patients (66%) as an adjuvant diagnostic method and to
rule out benign or malignant bronchial obstruction, and
for localization and collection of samples for microbiology.
We now consider it essential in the pre-operative evaluation
of all patients. In addition, it is currently routinely used for
bronchial toilet preoperatively.
Finally, pulmonary angiography was seldom required,
except in the cases with pulmonary hypertension, pulmon-
ary sequestration and severe haemoptysis, but this may
change, should the classi®cation of Ashour et al. [12]
prove to be of relevance in planning surgery.
Most of our patients underwent pre-operative ventilation
spirometry as part of pre-anaesthetic evaluation of their
respiratory function. As was the case with other series
[13,14], we found a normal ventilatory pattern in the major-
ity of the patients (66.3%) and an obstructive pattern in less
than one third. Although the exact cause of air¯ow obstruc-
tion in these cases is not known, a multi-factorial aetiology
is postulated, especially due to retention of thicken mucus or
to immunologic abnormalities. However, we only had three
cases of a-1 antitrypsin de®ciency and we had no case of
cystic ®brosis. Patients were physiologically evaluated
again at a minimum of 2 years after the operation. Compar-
ison of this data showed that surgery in¯uenced neither FVC
nor FEV1, despite parenchymal resection, not an unexpected
®nding, since the excised lung segments contributed little to
ventilation [14±19].
By contrast, we observed a considerable improvement of
the clinical condition in 96% of the cases. Only four patients
did not show improvement, three of whom had incomplete
resection, which is in accordance with other authors' experi-
ences [20]. Even among the nine patients who were
subjected to pneumonectomy, ®ve (56%) were asympto-
matic and another two (22%) were improved, and none
showed loss of ventilatory capacity. Seventy-®ve percent
of the patients who did not improve had incomplete resec-
tion and all had tuberculosis or asthma. Only one of the 11
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Table 4
Spirometry values measured pre and postoperatively (in % of expected)a
Pre-op Post-op P-value
FVC 90.8 ^ 18.8 89.2 ^ 13.6 0.70
FEV1 83.1 ^ 20.9 81.2 ^ 18.2 0.57
MEF50 58.6 ^ 32.9 53.5 ^ 26.1 0.26
a P  0:3.
Table 3
Symptomatic status of 108 follow-up patients (91%)
Symptoms Complete resection Incomplete resection Total
Asymptomatic 72 (74%) 1 (9%) 73 (68%)
Clinical improvement 24 (25%) 7 (64%) 31 (29%)
No improvement 1 (1%) 3 (27%) 4 (4%)
Total 97 (100%) 11 (11%) 108 (100%)
patients who had incomplete resection is asymptomatic.
Patients with bronchiectasis of tuberculous origin required
more extensive resection (24% had a pneumonectomy).
Fifty percent were asymptomatic at follow-up.
As other authors [21] have demonstrated, bilateral
bronchiectasis are not a contraindication to surgery and
even incomplete resection often results in considerable
bene®t to the patient. In the small group of 10 patients
with bilateral bronchiectasis, only two were operated on
both lungs; hence the resection was incomplete in eight.
In the majority of the cases, the decision to not perform a
second thoracotomy was the patient's own and was a direct
result of the clinical improvement after the initial procedure.
Two of these patients remained asymptomatic at the time of
follow-up.
In conclusion, surgical treatment of pulmonary bronch-
iectasis has few complications and can be carried out with-
out or with very low mortality and morbidity rates. It
improves symptoms, especially if all the diseased segments
of the lung are removed. Surgery does not alter FVC and
FEV1 meaningfully, certainly because of the little contribu-
tion of the resected segments of lung to ventilation. Our
results make us believe that surgery remains an excellent
alternative in the treatment of bronchiectasis and its compli-
cations. It aims at avoiding recurrences, long periods of
invalidating infectious symptoms and progression of the
disease, and at prevention of complications.
We realise that a mean follow-up of 4.5 years is too short
and that segments near the resected ones may become
bronchiectatic in some patients 10±15 years later. Nonethe-
less, having in mind the bene®ts derived in terms of quality
of life and of socio-economic impact (decreased hospital
admissions, of medicine consumption, and of absence
from work and loss of earnings), the attitude is evolving
towards the early use of surgery [22], rather than as a last
option in the treatment of the disease.
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Appendix A. Conference discussion
Dr K. Moghissi (Yorkshire Laser Centre, UK): The thing I would want to
ask you is that, in bronchiectasis it is not so clear-cut as in lobectomy or
segmentectomy. The situation is that you have got a left lower lobe bronch-
iectasis, but probably the apical segment of the lower lobe is not bronch-
iectatic and the inferior branch of the lingula on the left side is
bronchiectatic. There has been a lot of discussion about that. What would
you do in the situation where you have left the apical segment of the lower
lobe residual and now bronchiectasis has developed here after many years.
A number of cases in my series have developed bronchiectasis after 10, 15,
20 years.
Dr Antunes: This is a historical series, and 11 patients were not consid-
ered to have had a radical resection of the bronchiectasis. For one reason or
another, it was considered unwise to go further in the resection. As you saw,
the majority of those patients were still symptomatic. Some were improved,
but some were not improved at all. It may be that we did not do a correct
surgery to start with, but at that stage we thought we had gone as far as we
could go. I'm quite sure that some of those patients will eventually come up
for further resection, if it can be done. In the majority of cases we thought
that the restriction of ventilation precluded a larger resection, but it may be
necessary to reconsider that option for further treatment.
Dr R. Khan (Epsom, UK): I think you have probably answered my
question to a certain extent. You knew which were your incomplete resec-
tions before the commencement of your trial. The other thing is, the prin-
ciple of resection, it appears from your work, it has got to be very
conservative. You do not remove all visible disease. You remove only
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the totally damaged parts of the lung and the rest have got a high likelihood
of improvement. Could you comment on those two points, please?
Dr Antunes: We had 11 patients who had incomplete resection, and this
is a retrospective analysis, so we could only rely on the comments of the
surgeons on their operative reports. We have not been able to go back on
these patients who had incomplete resections to evaluate the three patients
who had no improvement at all and the seven patients who were improved
but were not completely asymptomatic. We don't know what their condi-
tion is, and the anatomical condition with regards to the disease, that is, if
they have evidence of bronchiectases.
Dr A. Varela (Madrid, Spain): I have two questions.
In bilateral disease what kind of approach do you use, and in this group of
patients did you have cystic ®brosis patients and what kind of resection?
Dr Antunes: I didn't refer to it here, but it is referred to in the manuscript.
Of the patients who had bilateral disease, and there were 10, only one had a
bilateral operation. Currently we prefer to do bilateral operations sequen-
tially, not in the same procedure. And the patients themselves opted for not
having a second operation because they were already markedly improved
from the ®rst one. It was the patients' option and we can always go back to
do the second lung operation, but we can only do that if the patients want it.
I don't know if we were suf®ciently persuasive to tell the patients: ªIf you
are left with some disease, then you can only get worse at a later stageº. But
after 5 years, the patients appeared to have a functional and stable clinical
condition. Again, at a much longer follow-up we may have to go back and
do either resection on the same side, if there are still some signs of disease,
or on the other side to tackle the disease, which was already present in 10
patients.
Dr Varela: How many patients diagnosed with cystic ®brosis?
Dr Antunes: There were 12 patients with cystic ®brosis.
Dr E. Ruf®ni (Torino, Italy): Have you ever observed in case of lower
lobe resection any recurrence of the disease in the lingular segment or in the
middle lobe which rotate downwards?
Dr Antunes: For some unknown reason, we had a larger than usual
number of patients with disease localized to the middle lobe. When we
had disease which was localized to the lower lobe, we were usually able to
resect the whole lobe and, therefore, completely eradicate the disease. But,
again, the follow-up was made only by questionnaire and we looked into the
functional assessment which had been done at one time or another for a
mean of 2 years. So we did not assess clinically all the patients in the end.
We wanted to know what the patients feel. I think we are now obliged to go
to that next step, and, at least for the patients who consider themselves not
asymptomatic, and that's one-third of the whole group, we will have to call
them and submit them to CAT scans. If they have disease which warrants
further surgery, this must be offered to them.
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